BIOMAT Database Logo BIOMAT Database Logo

Absorption of erythromycin propionate and triacetyloleandomycin. 1958

C M KUNIN, and H A HIRSCH, and M FINLAND

UI MeSH Term Description Entries
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014217 Troleandomycin A macrolide antibiotic that is similar to ERYTHROMYCIN. Triacetyloleandomycin,Oleandocetin,TAO

Related Publications

C M KUNIN, and H A HIRSCH, and M FINLAND
Effect of food on the absorption of erythromycin propionate, erythromycin stearate and triacetyloleandomycin.
June 1959, The American journal of the medical sciences,
C M KUNIN, and H A HIRSCH, and M FINLAND
Comparative studies of erythromycin propionate, erythromycin stearate, and triacetyloleandomycin.
February 1960, Antibiotic medicine & clinical therapy (New York, NY),
C M KUNIN, and H A HIRSCH, and M FINLAND
[Stabilization of pharmaceutical suspensions. 4. Xi-potential of erythromycin propionate and triacetyloleandomycin suspensions].
January 1974, Die Pharmazie,
C M KUNIN, and H A HIRSCH, and M FINLAND
Erythromycin, oleandomycin and triacetyloleandomycin.
February 1968, Pediatric clinics of North America,
C M KUNIN, and H A HIRSCH, and M FINLAND
Erythromycin propionate and estolate.
July 1988, Lancet (London, England),
C M KUNIN, and H A HIRSCH, and M FINLAND
Effect of food on absorption of a new form of erythromycin propionate.
February 1960, The American journal of the medical sciences,
C M KUNIN, and H A HIRSCH, and M FINLAND
[Effect of triacetyloleandomycin, erythromycin and spiramycin on mono-oxygenase activity].
January 1984, Eksperimentalna meditsina i morfologiia,
C M KUNIN, and H A HIRSCH, and M FINLAND
Pharmacology and toxicology of erythromycin propionate.
January 1958, Antibiotics annual,
C M KUNIN, and H A HIRSCH, and M FINLAND
Acid dye colourimetric and diphasic titrimetric determination of erythromycin and triacetyloleandomycin.
October 1972, Die Pharmazie,
C M KUNIN, and H A HIRSCH, and M FINLAND
Serum protein binding of erythromycin and erythromycin 2'-propionate ester.
March 1972, Journal of pharmaceutical sciences,
Copied contents to your clipboard!